Učitavanje...
Pembrolizumab‐related pancreatitis with elevation of pancreatic tumour markers
Lung cancer immunotherapy is an effective treatment option; however, it can be hampered by adverse events, including pancreatitis, associated with excessive immune activation. Here, we report the case of a 70‐year‐old patient who presented with recurrent lung squamous carcinoma and was started with...
Spremljeno u:
| Izdano u: | Respirol Case Rep |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley & Sons, Ltd
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7000995/ https://ncbi.nlm.nih.gov/pubmed/32042430 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rcr2.525 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|